Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
Medical Review Disclosure This content has been reviewed for medical accuracy. Always consult a qualified healthcare professional before making any
Cancer Medicine
Medical Review Disclosure
This content has been reviewed for medical accuracy. Always consult a qualified healthcare professional before making any medical decisions. [Last reviewed: 2026-02-11]
Lung cancer is one of the most common and deadly cancers globally. The most common type of lung cancer is non-small cell lung cancer (NSCLC). However, progress in medicine has given rise to targeted therapies that increase survival and quality of life.
One such miracle drug is Osimertinib (branded as Tagrisso). This work has been very effective, particularly in a subset of NSCLC patients that have a particular EGFR (Epidermal Growth Factor Receptor) mutation.
Osimertinib (Tagrisso): This is a targeted therapy for people with NSCLC and an EGFR mutation. This mutation results in uncontrolled growth of cancerous tissue until a tumor develops. Tagrisso works by blocking EGFR signals, which slows or stops cancer growth.
Unlike traditional chemotherapy, which kills all rapidly-dividing cells in the body, Osimertinib only targets cancerous cells and therefore inflicts less damage on normal, healthy cells.
In stage 4 NSCLC, Tagrisso has been shown to extend life expectancy beyond standard treatments. Some of the longest patients on Tagrisso have lived more than five years after diagnosis.
Tagrisso has demonstrated efficacy in stage 4 NSCLC.
Osimertinib (Tagrisso) Mechanism of Action:
Inhibition of the EGFR mutation – Which inhibits cancer cells from growing and spreading.
Crossing the Blood-Brain Barrier — This allows it to attack lung cancer cells in the brain where many other therapies cannot.
Shrinking Tumor Size – Often, tumors shrink in size, allowing better breathing and fewer symptoms
No, Tagrisso is not chemotherapy. Chemotherapy affects both cancerous and healthy cells — causing extreme side effects. Osimertinib is a targeted therapy, meaning it attacks lung cancer cells that have the EGFR mutation specifically, causing less damage to healthy cells.
Like any medication, Osimertinib has side effects, though they are usually milder than chemotherapy.
Heart Problems – It can cause irregular heartbeat (QT prolongation).
Lung Inflammation (Pneumonitis) – Some patients may develop serious lung inflammation.
Vision Changes – Blurry vision or eye problems have been reported.
This drug is among the most expensive cancer drugs. The Tagrisso price depends on location and insurance coverage:
If you are wondering where to buy Tagrisso, go to a doctor or a trusted pharmacy.
Tagrisso is a widely prescribed medication for EGFR-mutated non-small cell lung cancer (NSCLC), but its high cost can be a barrier for many patients. Osimert 80 mg Osimertinib offers a more affordable generic alternative with the same active ingredient (Osimertinib) and comparable effectiveness.
Yes,This medication inhibits cancer cell growth. It shrinks tumors and halts further spread, making it a potent weapon against lung cancer.
No, Tagrisso is a targeted therapy for lung cancer that is EGFR-positive.
Tagrisso does not cure cancer but can slow tumor growth and extend survival.
Yes, Tagrisso is active against lung cancer that has spread to the brain.
Some patients have been on Tagrisso for over five years, showing the longest patient on Tagrisso.
You can buy Tagrisso from MedsMonk, a trusted online pharmacy offering nationwide delivery nationwide.
You can inquire with us for the latest pricing and availability.
Osimertinib (Tagrisso) is a game-changer for lung cancer treatment. It increases life expectancy, boosts quality of life, and provides hope to NSCLC patients upon diagnosis.
If you or someone you know has been diagnosed with EGFR-mutated lung cancer, ask your doctor if Tagrisso is right for you. Although costly, assistance programs and financial aid may alleviate costs.
Medical Review Disclosure This content has been reviewed for medical accuracy. Always consult a qualified healthcare professional before making any
Medical Review Disclosure This content has been reviewed for medical accuracy. Always consult a qualified healthcare professional before making any
Medical Review Disclosure This content has been reviewed for medical accuracy. Always consult a qualified healthcare professional before making any
Our pharmacists can confirm availability, pricing and what your country requires for import.